Skip to main content
Log in

Possible digoxin toxicity associated with concomitant ciprofloxacin therapy

  • Case Report
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Case (Description)

A 27 year old female with a complex history of congenital heart disease, cardiac surgery, heart failure, and arrhythmias was admitted for a Pseudomonas aeruginosa sternal wound infection and treated with intravenous antibiotics. After discharge and completion of an outpatient course of intravenous antibiotics, suppressive antibiotic therapy with ciprofloxacin was initiated. She presented to clinic with nausea and anorexia within a few days of addition of ciprofloxacin to her current regimen of medications, which included digoxin. The digoxin was discontinued, with all other medications remaining the same, and the symptoms resolved in 48 h. The dose of digoxin was restarted at 50 % of the previous dose with no further complications. The proposed cause of the nausea and anorexia was digoxin toxicity secondary to a drug–drug interaction with ciprofloxacin.

Conclusion

Patients receiving ciprofloxacin and digoxin should be monitored closely for the risk of digoxin toxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Abad-Santos F, Carcas AJ, Ibanez C, Frias J. Digoxin level and clinical manifestations as determinants in the diagnosis of digoxin toxicity. Ther Drug Monit. 2000;22(2):163–8.

    Article  PubMed  CAS  Google Scholar 

  2. Gomes T, Mamdani MM, Juurlink DN. Macrolide-induced digoxin toxicity: a population-based study. Clin Pharmacol Ther. 2009;86(4):383–6.

    Article  PubMed  CAS  Google Scholar 

  3. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45.

    Article  PubMed  CAS  Google Scholar 

  4. Horn JR, Hansten PD, Chan LN. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother. 2007;41(4):674–80.

    Article  PubMed  Google Scholar 

  5. Hirata S, Izumi S, Furukubo T, et al. Interactions between clarithromycin and digoxin in patients with end-stage renal disease. Int J Clin Pharmacol Ther. 2005;43(1):30–6.

    Article  PubMed  CAS  Google Scholar 

  6. Constantine PA. Antibiotic therapy and serum digoxin toxicity. Am Fam Physician. 1998;57(6):1239–40.

    PubMed  CAS  Google Scholar 

  7. Sutton A, Pilot MA. Digoxin toxicity and erythromycin. BMJ. 1989;298(6680):1101.

    Article  PubMed  CAS  Google Scholar 

  8. Tsutsumi K, Kotegawa T, Kuranari M, et al. The effect of erythromycin and clarithromycin on the pharmacokinetics of intravenous digoxin in healthy volunteers. J Clin Pharmacol. 2002;42(10):1159–64.

    Article  PubMed  CAS  Google Scholar 

  9. American Pharmacists Association. Drug information handbook. 21st ed. Hudson, OH: Lexi-Comp; 2012.

    Google Scholar 

  10. Kiran N, Azam S, Dhakam S. Clarithromycin induced digoxin toxicity: case report and review. J Pak Med Assoc. 2004;54(8):440–1.

    PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None.

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Brady S. Moffett.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moffett, B.S., Valdes, S.O. & Kim, J.J. Possible digoxin toxicity associated with concomitant ciprofloxacin therapy. Int J Clin Pharm 35, 673–676 (2013). https://doi.org/10.1007/s11096-013-9818-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-013-9818-4

Keywords

Navigation